These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Neuropharmacology of addiction--setting the scene. Lawrence AJ; Beart PM; Kalivas PW Br J Pharmacol; 2008 May; 154(2):259-60. PubMed ID: 18414384 [TBL] [Abstract][Full Text] [Related]
3. Epigenetics: a link between addiction and social environment. Ajonijebu DC; Abboussi O; Russell VA; Mabandla MV; Daniels WMU Cell Mol Life Sci; 2017 Aug; 74(15):2735-2747. PubMed ID: 28255755 [TBL] [Abstract][Full Text] [Related]
4. New approach to the neurobiological mechanisms of addiction. Fürst Z; Riba P; Al-Khrasani M Neuropsychopharmacol Hung; 2013 Dec; 15(4):189-205. PubMed ID: 24380960 [TBL] [Abstract][Full Text] [Related]
5. Health for life. Addiction: how to break the chain. Miller MC Newsweek; 2005 Dec; 146(24):58. PubMed ID: 16375164 [No Abstract] [Full Text] [Related]
6. Targeting the Oxytocin System to Treat Addictive Disorders: Rationale and Progress to Date. Lee MR; Rohn MC; Tanda G; Leggio L CNS Drugs; 2016 Feb; 30(2):109-23. PubMed ID: 26932552 [TBL] [Abstract][Full Text] [Related]
7. Drugs of abuse: epigenetic mechanisms in toxicity and addiction. Kovatsi L; Fragou D; Samanidou V; Njau S; Kouidou S Curr Med Chem; 2011; 18(12):1765-74. PubMed ID: 21466474 [TBL] [Abstract][Full Text] [Related]
8. Epigenetic regulation of motivated behaviors by histone deacetylase inhibitors. Elvir L; Duclot F; Wang Z; Kabbaj M Neurosci Biobehav Rev; 2019 Oct; 105():305-317. PubMed ID: 29020607 [TBL] [Abstract][Full Text] [Related]
9. Drugs and addiction: an introduction to epigenetics. Wong CC; Mill J; Fernandes C Addiction; 2011 Mar; 106(3):480-9. PubMed ID: 21205049 [TBL] [Abstract][Full Text] [Related]
10. Pharmacotherapy of addictive disorders. Ross S; Peselow E Clin Neuropharmacol; 2009; 32(5):277-89. PubMed ID: 19834993 [TBL] [Abstract][Full Text] [Related]
11. Neuro-chemical activation of brain reward meso-limbic circuitry is associated with relapse prevention and drug hunger: a hypothesis. Blum K; Gold MS Med Hypotheses; 2011 Apr; 76(4):576-84. PubMed ID: 21306831 [TBL] [Abstract][Full Text] [Related]
12. Rebalancing the Addicted Brain: Oxytocin Interference with the Neural Substrates of Addiction. Bowen MT; Neumann ID Trends Neurosci; 2017 Dec; 40(12):691-708. PubMed ID: 29128108 [TBL] [Abstract][Full Text] [Related]
13. The epigenetic landscape of addiction. Maze I; Nestler EJ Ann N Y Acad Sci; 2011 Jan; 1216():99-113. PubMed ID: 21272014 [TBL] [Abstract][Full Text] [Related]
14. Sigma Receptors and Substance Use Disorders. Sabino V; Hicks C; Cottone P Adv Exp Med Biol; 2017; 964():177-199. PubMed ID: 28315272 [TBL] [Abstract][Full Text] [Related]
15. The Multidimensional Therapeutic Potential of Targeting the Brain Oxytocin System for the Treatment of Substance Use Disorders. Bowen MT; Neumann ID Curr Top Behav Neurosci; 2018; 35():269-287. PubMed ID: 28942596 [TBL] [Abstract][Full Text] [Related]
16. Epigenetics of addiction. Cadet JL; Jayanthi S Neurochem Int; 2021 Jul; 147():105069. PubMed ID: 33992741 [TBL] [Abstract][Full Text] [Related]
17. A Shared Molecular and Genetic Basis for Food and Drug Addiction: Overcoming Hypodopaminergic Trait/State by Incorporating Dopamine Agonistic Therapy in Psychiatry. Gold MS; Badgaiyan RD; Blum K Psychiatr Clin North Am; 2015 Sep; 38(3):419-62. PubMed ID: 26300032 [TBL] [Abstract][Full Text] [Related]
18. It is a complex issue: emerging connections between epigenetic regulators in drug addiction. Anderson EM; Penrod RD; Barry SM; Hughes BW; Taniguchi M; Cowan CW Eur J Neurosci; 2019 Aug; 50(3):2477-2491. PubMed ID: 30251397 [TBL] [Abstract][Full Text] [Related]
19. Transcriptional and epigenetic mechanisms of addiction. Robison AJ; Nestler EJ Nat Rev Neurosci; 2011 Oct; 12(11):623-37. PubMed ID: 21989194 [TBL] [Abstract][Full Text] [Related]
20. Effects of Kappa opioid receptor blockade by LY2444296 HCl, a selective short-acting antagonist, during chronic extended access cocaine self-administration and re-exposure in rat. Valenza M; Windisch KA; Butelman ER; Reed B; Kreek MJ Psychopharmacology (Berl); 2020 Apr; 237(4):1147-1160. PubMed ID: 31915862 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]